Clinical implementation of partial oral treatment in infective endocarditis: the Danish POETry study

Mia Marie Pries-Heje*, Julie Glud Hjulmand, Ingrid Try Lenz, Rasmus Bo Hasselbalch, Jonas Agerlund Povlsen, Nikolaj Ihlemann, Nana Køber, Marlene Lyngborg Tofterup, Lauge Østergaard, Morten Dalsgaard, Daniel Faurholt-Jepsen, Malene Wienberg, Ulrik Christiansen, Niels Eske Bruun, Emil Fosbøl, Claus Moser, Kasper Karmark Iversen, Henning Bundgaard

*Kontaktforfatter

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

7 Citationer (Scopus)

Abstract

Background and aims: In the Partial Oral Treatment of Endocarditis (POET) trial, stabilized patients with left-sided infective endocarditis (IE) were randomized to oral step-down antibiotic therapy (PO) or conventional continued intravenous antibiotic treatment (IV), showing non-inferiority after 6 months. In this study, the first guideline-driven clinical implementation of the oral step-down POET regimen was examined.

Methods: Patients with IE, caused by Staphylococcus aureus, Enterococcus faecalis, Streptococcus spp. or coagulase-negative staphylococci diagnosed between May 2019 and December 2020 were possible candidates for initiation of oral step-down antibiotic therapy, at the discretion of the treating physician. The composite primary outcome in patients finalizing antibiotic treatment consisted of embolic events, unplanned cardiac surgery, relapse of bacteraemia and all-cause mortality within 6 months.

Results: A total of 562 patients [median age 74 years (IQR, interquartile range, 65-80), 70% males] with IE were possible candidates; PO was given to 240 (43%) patients and IV to 322 (57%) patients. More patients in the IV group had IE caused by S. aureus, or had an intra-cardiac abscess, or a pacemaker and more were surgically treated. The primary outcome occurred in 30 (13%) patients in the PO group and in 59 (18%) patients in the IV group (P = .051); in the PO group, 20 (8%) patients died vs. 46 (14%) patients in the IV group (P = .024). PO-treated patients had a shorter median length of stay [PO 24 days (IQR 17-36) vs. IV 43 days (IQR 32-51), P < .001].

Conclusions: After clinical implementation of the POET regimen almost half of the possible candidates with IE received oral step-down antibiotic therapy. Patients in the IV group had more serious risk factors for negative outcomes. At 6-month follow-up, there was a numerically but not statistically significant difference towards a lower incidence of the primary outcome, a lower incidence of all-cause mortality and a reduced length of stay in the PO group. Due to the observational design of the study, the lower mortality may to some extent reflect selection bias and unmeasured confounding. Clinical implementation of PO regimens seemed feasible and safe.
OriginalsprogEngelsk
Artikelnummerehad715
TidsskriftEuropean Heart Journal
Vol/bind44
Udgave nummer48
Sider (fra-til)5095-5106
Antal sider12
ISSN0195-668X
DOI
StatusUdgivet - 21 dec. 2023

Bibliografisk note

© The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For permissions, please e-mail: [email protected].

Fingeraftryk

Dyk ned i forskningsemnerne om 'Clinical implementation of partial oral treatment in infective endocarditis: the Danish POETry study'. Sammen danner de et unikt fingeraftryk.

Citationsformater